drugset / Trial / NCT05236738
A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the drug absorption of atazanavir and cobicistat between the coadministration of the mini-tablet formulations in applesauce or chocolate pudding followed by water and the coadministration of atazanavir oral powder in applesauce and cobicistat oral tablet followed by water in healthy adult participants.
Timeline
- Start
- 2022-05-13
- Primary completion
- 2022-07-05
- Completion
- 2022-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atazanavir | Other / unclassified | 300 mg | Oral |
| Subject | Atazanavir/Cobicistat | Unknown | 150 mg | Oral |
| Subject | Atazanavir/Cobicistat | Unknown | 300 mg | Oral |
| Subject | Cobicistat | Small molecule | 150 mg | Oral |
Indications
No indication recorded.